Simplify Asset Management »

Adaptimmune Therapeutics shares owned by Simplify Asset Management

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $117k 150k 0.78
2023-06-30 $139k 150k 0.93
2023-03-31 $164k 150k 1.09

More positions owned by Simplify Asset Management

Ishares Tr 20 Yr Tr Bd Etf Put Option (TLT)
Ishares Tr Core S&p500 Etf (IVV)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Simplify Exchange Traded Fun Stable Incm Etf (BUCK)
Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Pimco Etf Tr 15+ Yr Us Tips (LTPZ)
Tesla Motors Call Option (TSLA)
Applied Therapeutics (APLT)
Ishares Tr Core Us Aggbd Et (AGG)
Simplify Exchange Traded Fun Short Term Trea (TUA)
Ishares Tr Mbs Etf (MBB)
Tscan Therapeutics (TCRX)
Simplify Exchange Traded Fun High Yield Plus (CDX)

View all positions for Simplify Asset Management

Top funds holding Adaptimmune Therapeutics

NEA Management Company
Baillie Gifford & Co
Long Focus Capital Management
Baker Bros. Advisors
Partner Fund Management
Bank of America Corporation
Tang Capital Management
Citadel Advisors
Syncona Portfolio
Jpmorgan Chase & Co
Redmile Group
GSA Capital Partners
Acuitas Investments
Millennium Management
DAFNA Capital Management

View all funds holding Adaptimmune Therapeutics